Dear Researchers,

The library will operate on a duty schedule between 22 December 2025 and 4 January 2026. During this period, it will be possible to upload publications, but all other services will be suspended.

Thank you for your understanding.

Ruzsnavszky Ferenc

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2006-2017

2017

Hegyi, B., Horváth, B., Váczi, K., Gönczi, M., Kistamás, K., Ruzsnavszky, F., Veress, R., Izu, L. T., Chen-Izu, Y., Bányász, T., Magyar, J., Csernoch, L., Nánási, P. P., Szentandrássy, N.: Ca2+-activated Cl- current is antiarrhythmic by reducing both spatial and temporal heterogeneity of cardiac repolarization.
J. Mol. Cell. Cardiol. 109, 27-37, 2017.

doi DEA WoS Scopus

Journal metrics:

D1 Cardiology and Cardiovascular Medicine

Q1 Molecular Biology

Szentandrássy, N., Hegyi, B., Horváth, B., Váczi, K., Gönczi, M., Dienes, B., Kistamás, K., Veress, R., Ruzsnavszky, F., Bányász, T., Magyar, J., Baczkó, I., Varró, A., Seprényi, G., Csernoch, L., Nánási, P. P.: Recent advances in research of cardiac calcium-activated chloride channels.
Acta Physiol. 221 (S713), 22, 2017.

DEA

2016

Dini, P., Karimi, F., Nehaniv, C. L., Bonivárt, Á., Horváth, G., Muzsnay, Z., Figula, Á., Milkovszki, T., Munro, A. J., Ruzsnavszky, F.: Further Analysis of Cellular Pathways.
Biological and Mathematical Basis of InteractionComputing, [s.l.], 98 p., 2016.

DEA

2015

Váczi, K., Hegyi, B., Ruzsnavszky, F., Kistamás, K., Horváth, B., Bányász, T., Nánási, P. P., Szentandrássy, N., Magyar, J.: 9-Anthracene carboxylic acid is more suitable than DIDS for characterization of calcium-activated chloride current during canine ventricular action potential.
Naunyn-Schmiedebergs Arch. Pharmacol. 388 (1), 87-100, 2015.

doi DEA

Journal metrics:

Q2 Medicine (miscellaneous)

Q2 Pharmacology

Kistamás, K., Szentandrássy, N., Hegyi, B., Váczi, K., Ruzsnavszky, F., Horváth, B., Bányász, T., Nánási, P. P., Magyar, J.: Changes in intracellular calcium concentration influence beat-to-beat variability of action potential duration in canine ventricular myocytes.
J. Physiol. Pharmacol. 66 (1), 73-81, 2015.

DEA

Journal metrics:

Q1 Medicine (miscellaneous)

Q2 Pharmacology

Q2 Physiology

Szentandrássy, N., Kistamás, K., Hegyi, B., Horváth, B., Ruzsnavszky, F., Váczi, K., Magyar, J., Bányász, T., Varró, A., Nánási, P. P.: Contribution of ion currents to beat-to-beat variability of action potential duration in canine ventricular myocytes.
Pflügers Arch. 467 (7), 1431-1443, 2015.

doi DEA

Journal metrics:

D1 Clinical Biochemistry

Q1 Physiology

Q1 Physiology (medical)

2014

Ruzsnavszky, F., Hegyi, B., Kistamás, K., Váczi, K., Horváth, B., Szentandrássy, N., Bányász, T., Nánási, P. P., Magyar, J.: Asynchronous activation of calcium and potassium currents by isoproterenol in canine ventricular myocytes.
Naunyn-Schmiedebergs Arch. Pharmacol. 387 (5), 457-467, 2014.

doi DEA

Journal metrics:

Q1 Medicine (miscellaneous)

Q2 Pharmacology

Váczi, K., Hegyi, B., Ruzsnavszky, F., Kistamás, K., Horváth, B., Szentandrássy, N., Bányász, T., Nánási, P. P., Magyar, J.: The short term beat-to-beat variability of action potential duration depends on the length of action potential and intracellular calcium.
Acta Physiol. 211 (s697), 80, 2014.

DEA

2013

Kistamás, K., Szentandrássy, N., Hegyi, B., Ruzsnavszky, F., Váczi, K., Bárándi, L., Horváth, B., Szebeni, A., Magyar, J., Bányász, T., Kecskeméti, V., Nánási, P. P.: Effects of pioglitazone on cardiac ion currents and action potential morphology in canine ventricular myocytes.
Eur. J. Pharmacol. 710 (1-3), 10-19, 2013.

doi DEA WoS Scopus

Journal metrics:

Q2 Pharmacology

10.

Szabó, L., Szentandrássy, N., Kistamás, K., Hegyi, B., Ruzsnavszky, F., Váczi, K., Horváth, B., Magyar, J., Bányász, T., Pál, B., Nánási, P. P.: Effects of tacrolimus on action potential configuration and transmembrane ion currents in canine ventricular cells.
Naunyn-Schmiedebergs Arch. Pharmacol. 386 (3), 239-246, 2013.

doi DEA WoS Scopus

Journal metrics:

Q1 Medicine (miscellaneous)

Q2 Pharmacology

11.

Jenes, Á., Szigeti, G., Ruzsnavszky, F., Varga, A., Lőrincz, L., Csernoch, L.: Nicotine interferes with purinergic signaling in smooth muscle cells isolated from urinary bladders of patients with lower urinary tract symptoms.
Gen. Physiol. Biophys. 32 (3), 295-302, 2013.

doi DEA

Journal metrics:

Q3 Biophysics

Q3 Medicine (miscellaneous)

Q4 Physiology

12.

Hegyi, B., Komáromi, I., Kistamás, K., Ruzsnavszky, F., Váczi, K., Horváth, B., Magyar, J., Bányász, T., Nánási, P. P., Szentandrássy, N.: Tetrodotoxin Blockade on Canine Cardiac L-Type Ca2+ Channels Depends on pH and Redox Potential.
Mar Drugs. 11 (6), 2140-2153, 2013.

doi DEA

Journal metrics:

Q2 Drug Discovery

2012

13.

Jenes, Á., Ruzsnavszky, F., Telek, A., Szigeti, G., Csernoch, L.: A possible role of the cholinergic and purinergic receptor interaction in the regulation of the rat urinary bladder function.
J. Muscle Res. Cell Motil. 32 (6), 421-431, 2012.

doi DEA

Journal metrics:

Q3 Biochemistry

Q3 Cell Biology

Q3 Physiology

14.

Farkas, V., Szentandrássy, N., Bárándi, L., Hegyi, B., Ruzsnavszky, F., Ruzsnavszky, O., Horváth, B., Bányász, T., Magyar, J., Márton, I., Nánási, P. P.: Interaction between Ca2+ channel blockers and isoproterenol on L-type Ca2+ current in canine ventricular cardiomyocytes.
Acta Physiol. 206 (1), 42-50, 2012.

doi DEA

Journal metrics:

Q1 Physiology

15.

Szentandrássy, N., Farkas, V., Bárándi, L., Hegyi, B., Ruzsnavszky, F., Horváth, B., Bányász, T., Magyar, J., Márton, I., Nánási, P. P.: Role of action potential configuration and the contribution of Ca2+ and K+ currents to isoprenaline-induced changes in canine ventricular cells.
Br. J. Pharmacol. 167 (3), 599-611, 2012.

doi DEA

Journal metrics:

D1 Pharmacology

16.

Czikora, Á., Lizanecz, E., Bakó, P., Rutkai, I., Ruzsnavszky, F., Magyar, J., Pórszász, R., Kark, T., Facskó, A., Papp, Z., Édes, I., Tóth, A.: Structure-activity relationships of vanilloid receptor agonists for arteriolar TRPV1.
Br. J. Pharmacol. 165 (6), 1801-1812, 2012.

doi DEA

Journal metrics:

D1 Pharmacology

2011

17.

Harmati, G., Papp, F., Szentandrássy, N., Bárándi, L., Ruzsnavszky, F., Horváth, B., Bányász, T., Magyar, J., Panyi, G., Krasznai, Z., Nánási, P. P.: Effects of the PKC inhibitors chelerythrine and bisindolylmaleimide I (GF 109203X) on delayed rectifier K(+) currents.
Naunyn Schmiedebergs Arch. Pharmacol. 383 (2), 141-148, 2011.

doi DEA

Journal metrics:

Q1 Medicine (miscellaneous)

Q1 Pharmacology

18.

Magyar, J., Jenes, Á., Kistamás, K., Ruzsnavszky, F., Nánási, P. P., Satin, J., Szentandrássy, N., Bányász, T.: Long term regulation of cardiac L-type calcium channel by small G proteins.
Curr. Med. Chem. 18 (24), 3714-3719, 2011.

doi DEA WoS Scopus

Journal metrics:

Q1 Molecular Medicine

Q1 Pharmacology

19.

Szentandrássy, N., Nagy, D., Ruzsnavszky, F., Harmati, G., Bányász, T., Magyar, J., Szentmiklósi, J. A., Nánási, P. P.: Powerful technique to test selectivity of agents acting on cardiac ion channels: the action potential voltage-clamp.
Curr. Med. Chem. 18 (24), 3737-3756, 2011.

doi DEA

Journal metrics:

Q1 Molecular Medicine

Q1 Pharmacology

2006

20.

Jenes, Á., Ruzsnavszky, F., Széll, E. A., Varga, A., Somogyi, G. T., Csernoch, L., Szigeti, G.: The role of the cholinergic and purinergic interaction in the contraction of the cultured human and rat urinary bladder smooth muscle cells.
J. Muscle Res. Cell Motil. 27, 498, 2006.